N/A
Manufactured by Biogen Inc.
233,327 FDA adverse event reports analyzed
Last updated: 2026-05-19
Tecfidera is a medication tracked in the FDA Adverse Event Reporting System (FAERS), manufactured by Biogen Inc.. The most commonly reported adverse reactions for Tecfidera include FLUSHING, NAUSEA, DIARRHOEA, MULTIPLE SCLEROSIS RELAPSE, FATIGUE. This page provides a comprehensive breakdown of reported side effects, safety signals, patient demographics, and AI-powered safety analysis for Tecfidera.
Out of 122,008 classified reports for Tecfidera:
The FDA classifies an adverse event as “serious” if it results in death, hospitalization, disability, congenital anomaly, or requires intervention to prevent permanent damage.
Demographics reflect voluntary FDA adverse event reporting patterns and may not represent the full patient population.
This profile reflects 233,327 FDA FAERS reports that mention Tecfidera. Reporting is voluntary and does not prove that the drug caused any listed event.
Frequently reported terms in FAERS include FLUSHING, NAUSEA, DIARRHOEA, MULTIPLE SCLEROSIS RELAPSE, FATIGUE, MULTIPLE SCLEROSIS. Rankings reflect reporting volume in this dataset, not confirmed side effect rates in the general population.
Labeling and FAERS entries often list Biogen Inc. in connection with Tecfidera. Always verify the specific product and NDC with your pharmacist.
Explore other medications manufactured by Biogen Inc. and compare their safety profiles:
The following drugs share commonly reported adverse reactions with Tecfidera: